Skip to content
Search

Latest Stories

Pharma sector needs protecting from Trump tariffs, warn MPs

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.


There are a large number of pharmaceutical companies based in Oxfordshire and the wider Thames Valley region.

"Trump’s trade war has already caused catastrophic damage and I’m particularly concerned about what possible pharmaceutical tariffs might mean,” said Glover, Liberal Democrat MP for Didcot and Wantage.

"Pharmaceutical industry jobs are especially important here in Oxfordshire, with Milton Park in my constituency being a crucial hub for pharmaceutical innovation.

"It is vital that they are protected."

Trump has enacted sweeping changes on a wide range of U.S. domestic and foreign policy priorities since taking office on January 20. He has upended the world economic order with tariffs, slashed the federal government with job cuts and done away with diversity programs in the public and private sector.

The president launched an all-out trade war on numerous countries this year before putting reciprocal tariffs largely on hold to allow for negotiations with individual nations. His administration hopes to secure agreements within 90 days.

The UK has pushed for a trade deal with the US in the hope that this could soften the impact of the Trump tariffs.

Trump's press secretary Karoline Leavitt said yesterday that trade talks were "moving in a very positive way".

The MPs' call comes as some companies that rely heavily on exports to the US are reportedly considering moving their manufacturing from the UK to America, according to RBC analysts.

"The life sciences sector needs a genuine industrial strategy to support growth and provide the conditions for growth, not just warm words from the government,” said van Mierlo, MP for Henley and Thame and chair of the All Party Parliamentary Group on Access to Medicines

"Manufacturing of advanced therapeutics should go alongside our thriving research and innovation sector.

"It is also vital that ministers take steps to reassure the public and prepare for every scenario that the chaotic Trump administration could force upon us."

Mierlo called for the creation of a government task force to help protect people and pharmaceutical companies, both nationally and in Oxfordshire.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less